Home / Stocks / Deepak Nitrite Ltd
DEEPAKNTR

Deepak Nitrite Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹1,587.1

Change

-13.8 (-0.86%)

Open

₹1,601.1

Prev. Close

₹1,600.9

Day High

₹1,608.3

Day Low

₹1,575.0

Volume Analysis

Traded

69,925

Delivered

33,440

Delivery %

47.82%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (1)

  • •Low return on equity (9.82%)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹1,638.56 ₹1,623.43 ₹1,605.26 ₹1,590.13 ₹1,571.96 ₹1,556.83 ₹1,538.66
Fibonacci ₹1,623.43 ₹1,610.71 ₹1,602.85 ₹1,590.13 ₹1,577.41 ₹1,569.55 ₹1,556.83
Camarilla ₹1,596.26 ₹1,593.21 ₹1,590.15 ₹1,590.13 ₹1,584.05 ₹1,581.0 ₹1,577.94

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-6.71%

1 Week

+0.05%

1 Month

-9.97%

3 Months

+2.63%

6 Months

+17.37%

1 Year

-14.14%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹623.43

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

12.3%

Net margin 9.13% × asset turnover 0.91x × equity multiplier 1.48x

Company Overview

Sector

Chemicals

Market Cap

₹22,299 Cr

P/E (TTM)

28.1

ROE

9.82%

Book Value

₹428.0

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.

TopFund Analysis

Deepak Nitrite Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 57/100. The strongest factor is Financial Strength (100/100), while Growth (15/100) is the weakest area to weigh before deciding. Notably: Low return on equity (9.82%).

TopFund Score — Fundamentals Quality

57/100 — Average

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

100

Growth

15

Valuation

48

Cash Flow

18

Corporate Governance

88

Momentum

57

Institutional Ownership

62

Business Quality

59

Risk & Volatility

71

Liquidity

55

From Screener.in

  • −Company has a low return on equity of 12.8% over last 3 years.
  • −Company might be capitalizing the interest cost

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

DNL and DPL invested ₹175 crore in DCTL via OCRPS allotment on 26 August 2026.

Subsidiary settled factories-rule violation for ₹3,00,000 on 25 August 2026.

Puneet Sharma resigned as SBU Head - Life Sciences, effective close of business 21 August 2026.

Board changes effective from August 7, 2026; updated 13-member board disclosed.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 1,768 1,778 2,009 2,126 2,167 2,032 1,903 2,180 1,890 1,902 1,975 2,120 2,578
Expenses + 1,559 1,476 1,705 1,825 1,858 1,734 1,735 1,863 1,700 1,698 1,764 1,744 2,037
Operating Profit 210 302 305 301 309 298 169 317 190 204 211 376 540
OPM % 12.0% 17.0% 15.0% 14.0% 14.0% 15.0% 9.0% 15.0% 10.0% 11.0% 11.0% 18.0% 21.0%
Other Income + 32 17 14 99 19 21 21 23 25 20 -4 7 14
Interest 2 3 3 4 6 6 6 9 8 8 11 19 23
Depreciation 38 39 42 46 47 48 48 51 51 53 58 63 64
Profit before tax 202 277 274 349 275 264 135 279 155 163 138 301 468
Tax % 26.0% 26.0% 26.0% 27.0% 26.0% 26.0% 27.0% 27.0% 27.0% 27.0% 28.0% 27.0% 26.0%
Net Profit + 150 205 202 254 203 194 98 202 112 119 100 220 345
EPS in Rs 11 15 15 19 15 14 7 15 8 9 7 16 25
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 1,327 1,373 1,371 1,651 2,700 4,230 4,360 6,802 7,972 7,682 8,282 7,887 8,575
Expenses + 1,187 1,204 1,231 1,447 2,278 3,194 3,108 5,196 6,680 6,555 7,187 6,900 7,243
Operating Profit 140 169 139 204 421 1,035 1,252 1,607 1,292 1,127 1,095 987 1,331
OPM % 11.0% 12.0% 10.0% 12.0% 16.0% 24.0% 29.0% 24.0% 16.0% 15.0% 13.0% 13.0% 16.0%
Other Income + 1 0 80 7 11 29 20 42 46 156 84 44 36
Interest 38 40 37 47 87 118 77 36 27 15 31 49 61
Depreciation 36 40 48 53 78 140 153 178 166 166 195 225 237
Profit before tax 67 89 135 111 268 806 1,042 1,434 1,146 1,102 953 757 1,070
Tax % 21.0% 29.0% 28.0% 29.0% 35.0% 24.0% 26.0% 26.0% 26.0% 26.0% 27.0% 27.0% —
Net Profit + 53 63 96 79 174 611 776 1,067 852 811 697 551 783
EPS in Rs 5 5 7 6 13 45 57 78 62 59 51 40 57
Dividend Payout % 20.0% 22.0% 16.0% 22.0% 16.0% 10.0% 10.0% 9.0% 12.0% 13.0% 15.0% 19.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 325 450 689 895 1,044 1,545 2,319 3,311 4,063 4,769 5,361 5,810
Borrowings + 545 529 724 987 1,187 1,107 590 315 73 286 1,267 1,638
Other Liabilities + 235 295 350 684 677 538 630 779 967 1,012 1,053 1,180
Total Liabilities 1,125 1,296 1,789 2,592 2,935 3,217 3,567 4,432 5,129 6,095 7,708 8,654
Fixed Assets + 549 594 586 588 1,716 1,832 1,864 1,963 1,942 2,293 2,457 3,270
CWIP 44 36 349 955 34 172 220 122 301 774 1,649 1,828
Investments 3 87 118 32 2 2 189 439 379 122 511 213
Other Assets + 530 580 736 1,018 1,183 1,210 1,293 1,908 2,508 2,907 3,091 3,343
Total Assets 1,125 1,296 1,789 2,592 2,935 3,217 3,567 4,432 5,129 6,095 7,708 8,654
Equity Capital 21 23 26 27 27 27 27 27 27 27 27 27

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 108 167 49 183 60 765 1,002 824 650 874 625 539
Cash from Investing Activity + -89 -169 -353 -525 -163 -428 -396 -424 -276 -717 -1,489 -669
Cash from Financing Activity + -22 4 305 345 96 -338 -599 -386 -359 44 806 193
Net Cash Flow -3 2 1 4 -6 -1 7 14 15 200 -59 64
CFO/OP 87 110 47 103 28 93 99 73 70 101 77 74
Free Cash Flow 18 81 -192 -438 -194 349 788 638 290 110 -494 -658

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 49.13% → 49.34%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 26.45% 25.52% 24.87% 22.7% 21.79% 20.94% 20.84% 21.42% 21.82% 21.42% 21.01% 20.65%
Promoters 49.13% 49.13% 49.13% 49.24% 49.24% 49.24% 49.28% 49.28% 49.28% 49.33% 49.33% 49.34%
FII 6.47% 6.48% 6.72% 6.86% 6.68% 6.59% 6.64% 6.68% 6.21% 6.06% 6.19% 6.24%
DII 17.96% 18.87% 19.27% 21.2% 22.3% 23.22% 23.22% 22.61% 22.7% 23.2% 23.46% 23.76%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Chemicals — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Deepak Nitrite Ltd (this stock) 22,299 28.1 3.82 9.82%
Sumitomo Chem India Ltd 22,279 39.0 6.57 16.2%
Aether Industries Limited 21,850 91.1 8.9 9.66%
Atul Ltd 17,962 22.6 2.89 11.5%
Aarti Industries Ltd 17,754 34.0 2.98 7.13%
Deepak Fertilizers & Petr 17,490 17.8 2.56 10.9%
Bayer Cropscience Ltd 16,957 344.0 44.65 15.8%

Which Mutual Funds Hold Deepak Nitrite Ltd?

Frequently Asked Questions about Deepak Nitrite Ltd

Community Sentiment

What are other investors saying about Deepak Nitrite Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.